Alpha Zero
VRTX icon

Alpha Zero’s Vertex Pharmaceuticals VRTX Stock Holding History

Alpha Zero’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$682K Buy
1,305
+391
+43% +$200K 0.23% 55
2026
Q2 		$444K Buy
914
+229
+33% +$101K 0.17% 67
2026
Q1 		$306K Sell
685
-23
-3% -$10.7K 0.15% 62
2025
Q4 		$321K Sell
708
-27
-4% -$11.6K 0.18% 51
2025
Q3 		$288K Buy
735
+74
+11% +$30.9K 0.17% 51
2025
Q2 		$294K Buy
661
+56
+9% +$25.8K 0.19% 49
2025
Q1 		$293K Sell
605
-5
-0.8% -$2.33K 0.22% 50
2024
Q4 		$246K Buy
+610
New +$283K 0.18% 63

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Alpha Zero's VRTX Position: Q3 2026 in Review

Alpha Zero increased its Vertex Pharmaceuticals (VRTX) stake by 43% in Q3 2026, buying an estimated $200K and bringing the position to 1,305 shares worth $682K. The position accounts for 0.23% of the portfolio, ranked #55.

Alpha Zero first reported a position in VRTX in Q4 2024 and has held it in 8 quarters since. 1,485 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Alpha Zero held 1,305 shares of Vertex Pharmaceuticals worth $682K as of Q3 2026.
  • Alpha Zero bought 391 Vertex Pharmaceuticals shares in Q3 2026, an estimated $200K.
  • Vertex Pharmaceuticals made up 0.23% of Alpha Zero's portfolio in Q3 2026, its #55 holding.
  • Alpha Zero first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
  • 1,485 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Alpha Zero's 13F filing for Q3 2026, filed 6 Nov 2026.